These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24677814)

  • 1. Characterization of individual mouse cerebrospinal fluid proteomes.
    Smith JS; Angel TE; Chavkin C; Orton DJ; Moore RJ; Smith RD
    Proteomics; 2014 May; 14(9):1102-6. PubMed ID: 24677814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
    Macron C; Lane L; Núñez Galindo A; Dayon L
    J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly maturing field of proteomics: a gateway to studying diseases.
    Schutzer SE
    Proteomics; 2014 May; 14(9):991-3. PubMed ID: 24668871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
    Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R
    Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
    Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
    Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
    Macron C; Núñez Galindo A; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of human cerebrospinal fluid for proteomics biomarker analysis.
    Waybright TJ
    Methods Mol Biol; 2013; 1002():61-70. PubMed ID: 23625394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: Evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral counting.
    Fratantoni SA; Piersma SR; Jimenez CR
    Proteomics Clin Appl; 2010 Jul; 4(6-7):613-7. PubMed ID: 21137079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
    Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
    Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics analysis of human cerebrospinal fluid.
    Yuan X; Desiderio DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the human ventricular cerebrospinal fluid proteome obtained from hydrocephalic patients.
    Waybright T; Avellino AM; Ellenbogen RG; Hollinger BJ; Veenstra TD; Morrison RS
    J Proteomics; 2010 Apr; 73(6):1156-62. PubMed ID: 20176152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of the cerebrospinal fluid peptidome and proteome.
    Zougman A; Pilch B; Podtelejnikov A; Kiehntopf M; Schnabel C; Kumar C; Mann M
    J Proteome Res; 2008 Jan; 7(1):386-99. PubMed ID: 18052119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Between-gel reproducibility of the human cerebrospinal fluid proteome.
    Terry DE; Desiderio DM
    Proteomics; 2003 Oct; 3(10):1962-79. PubMed ID: 14625859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).
    Guldbrandsen A; Farag YM; Lereim RR; Berven FS; Barsnes H
    Methods Mol Biol; 2019; 2044():377-391. PubMed ID: 31432427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of mouse astrocytes and their secretome by a combination of FASP and StageTip-based, high pH, reversed-phase fractionation.
    Han D; Jin J; Woo J; Min H; Kim Y
    Proteomics; 2014 Jul; 14(13-14):1604-9. PubMed ID: 24753479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
    Opsahl JA; Vaudel M; Guldbrandsen A; Aasebø E; Van Pesch V; Franciotta D; Myhr KM; Barsnes H; Berle M; Torkildsen Ø; Kroksveen AC; Berven FS
    Proteomics; 2016 Apr; 16(7):1154-65. PubMed ID: 26841090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Missing Proteins in Normal Human Cerebrospinal Fluid.
    Macron C; Lane L; Núñez Galindo A; Dayon L
    J Proteome Res; 2018 Dec; 17(12):4315-4319. PubMed ID: 30106588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Proteomic Analysis of Individual and Gender Variations in Normal Human Urine and Cerebrospinal Fluid Using iTRAQ Quantification.
    Guo Z; Zhang Y; Zou L; Wang D; Shao C; Wang Y; Sun W; Zhang L
    PLoS One; 2015; 10(7):e0133270. PubMed ID: 26222143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
    Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
    Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.